StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech cash

Cash and short-term investments held at the end of each period.

Burning Rock Biotech's cash was CN¥478.39M at Dec 31, 2025. For fiscal 2025 it was CN¥478.39M, down 8.0% from the year before. The highest annual figure on record is CN¥2.29B in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥478.39M-8.0%
FY2024Dec 31, 2024CN¥519.85M-15.5%
FY2023Dec 31, 2023CN¥615.10M-33.5%
FY2022Dec 31, 2022CN¥925.27M-38.4%
FY2021Dec 31, 2021CN¥1.50B-34.3%
FY2020Dec 31, 2020CN¥2.29B+454.9%
FY2019Dec 31, 2019CN¥412.23M+332.4%
FY2018Dec 31, 2018CN¥95.33M+74.0%
FY2017Dec 31, 2017CN¥54.79M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥478.39M-58.3%
Q4 FY2024Dec 31, 2024CN¥519.85M-65.4%
Q4 FY2023Dec 31, 2023CN¥615.10M-66.8%
Q4 FY2022Dec 31, 2022CN¥925.27M-59.5%
Q2 FY2022Jun 30, 2022CN¥1.15B+178.6%
Q4 FY2021Dec 31, 2021CN¥1.50B+1476.4%
Q2 FY2021Jun 30, 2021CN¥1.85B+3281.9%
Q4 FY2020Dec 31, 2020CN¥2.29B–
Q4 FY2019Dec 31, 2019CN¥412.23M–
Q4 FY2018Dec 31, 2018CN¥95.33M–
Q4 FY2017Dec 31, 2017CN¥54.79M–

More Burning Rock Biotech figures

See a number that looks wrong?